Added To 600,000 Tests, YHLO And C-Mer Donated COVID-19 Antigen Tests To Hong Kong Again
Time Posted ：2024-04-03
Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16. The total number of the donations increased to 600,000 tests. YHLO and C-Mer are joining hands to help Hong Kong citizens to fight against COVID-19.
View Details
Officially Established, YHLO Japan R&D Center Set sail
Time Posted ：2024-04-03
Recently, the opening ceremony of YHLO Japan Research and Development Center was successfully held online, which indicates that YHLO has stepped further toward globalization.
View Details
Meet YHLO at 13th International Autoimmunity Congress in Greece
Time Posted ：2024-04-03
YHLO showcased at 13th International Congress on Autoimmunity
Time Posted ：2024-04-03
From 10-13 June 2022, YHLO was grandly showcased at the 13th International Congress on Autoimmunity in Athens, Greece
View Details
Peking University—YHLO Joint Lab Achieved Another Great Result
Time Posted ：2024-03-04
On June 24th, Peking University—YHLO Joint Laboratory for Molecular Diagnostics of Infectious Diseases published in Journal of Infection（2021 IF: 38.637） an article entitled “Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study”, which revealed the immune response and protection against the Omicron variant before and after three doses of the inactivated COVID-19 vaccine.
View Details
YHLO COVID-19 Rapid Test Effectively Detect More Mutant Strains
Time Posted ：2024-03-04
Recently, the BA.5 and BA.4 variants of the Omicron subtype have spread rapidly in many countries and areas worldwide. The experts have analysed that due to the mutation of the SARS-CoV-2 spike protein again, the BA.4 and BA.5 variants are able to evade human immunity, which can lead to infection or reinfection of "almost everyone", including people who have been vaccinated or who have been cured from SARS-CoV-2.
View Details
YHLO Medical Device Industrial Park in Hunan Start Construction
Time Posted ：2024-03-04
On July 25, 2022, the YHLO Medical Device Industrial Park was announced to start construction in Hunan Province. The total area of construction is up to 200,000 square meters. It is estimated to be completed and put into production in July 2025. The park will be one of the research and development centres of the YHLO iModules Integration System for Immunoassay and the subsidiary brand Drawray microfluidics products. The new park will be the basic facility for YHLO’s further development.
View Details
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
